|
|
||||||||
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555
The cellular mechanisms of high dose systemic acetylcholine
receptor (AChR) T cell epitope,
146162 peptide-induced tolerance
in experimental myasthenia gravis were examined. CD4 cells are the
prime target for
146162 peptide-induced tolerance. The expression
of CD69, Fas, and B7.2 molecules on AChR-immune lymphocytes was
enhanced within 412 h after tolerance induction. A high dose of
146162 peptide in IFA failed to suppress T cell proliferation
and/or clinical myasthenia gravis in lpr and
gld mice deficient in Fas and Fas ligand, respectively.
A high dose of
146162 peptide in IFA in AChR-immunized mice
induced apoptosis of BV6 cells. Further, reconstitution of IL-2 in
vitro-recovered
146162 peptide tolerized T cell proliferation,
IFN-
, and IL-10 production. The findings implicate the possible role
of Fas-/Fas ligand-mediated apoptosis and the resulting clonal anergy
as the mechanisms of high dose AChR
146162 peptide-induced
tolerance on CD4 cells.
This article has been cited by other articles:
![]() |
H. Yang, M. Kala, B. G. Scott, E. Goluszko, H. A. Chapman, and P. Christadoss Cathepsin S Is Required for Murine Autoimmune Myasthenia Gravis Pathogenesis J. Immunol., February 1, 2005; 174(3): 1729 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Ferguson, J. Herndon, B. Elzey, T. S. Griffith, S. Schoenberger, and D. R. Green Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness J. Immunol., June 1, 2002; 168(11): 5589 - 5595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |